Analysis of the effects of different sites and surgical approaches on thoracoscopic radical lung cancer surgery complicated by celiac disease

doi:10.3969/j.issn.1009-976X.2023.01.005

Abstract

Abstract: Objective To investigate the effects of different parts and surgical methods of thoracoscopic lung cancer （segment group and lobe group, left and right group） on the incidence, treatment and prognosis of chylothorax. Methods The clinical data of 38 cases of chylothorax after radical resection of lung cancer in Ningbo Huamei Hospital of Chinese Academy of Sciences from January 2015 to December 2021 were retrospectively analyzed, including 1236 cases of segmental resection and 1236 cases of lobectomy, 952 cases of left thoracoscopic radical resection of lung cancer, 1520 cases of right thoracoscopic radical resection of lung cancer, 16 cases of chylothorax after segmental resection and systemic lymph node radical resection, 22 cases of chylothorax after lobectomy and systemic lymph node radical resection, 8 cases of chylothorax after left thoracoscopic radical resection of lung cancer, and 30 cases of chylothorax after right thoracoscopic radical resection of lung cancer. Results The total incidence of chylothorax after thoracoscopic lung cancer surgery was 1.54 %, the incidence of chylothorax in the lung segment group was 1.29 %, and the lung lobe group was 1.78 %. There was no significant difference between the two groups （P = 0.32）. The incidence of chylothorax after left thoracoscopic lung cancer was 0.63%, and the incidence of chylothorax after right thoracoscopic lung cancer was 2.11%, with significant difference （P <0.001）. All cases were successfully treated with conservative treatment, no deaths. Conclusion The incidence of chylothorax after lung cancer surgery was significantly correlated with the surgical site of lung cancer, but not with the surgical method of lung cancer. Treatment outcome： nutritional support for postoperative chylothorax of lung cancer improves the efficiency of conservative treatment.

Key words: lung cancer, chylothorax, thoracoscope

摘要： 目的探讨不同部位及手术方式（肺段组与肺叶组、左侧与右侧组）对胸腔镜肺癌根治术并发乳糜胸的发生率、治疗和转归的影响。方法回顾分析2015年1月~2021年12月中国科学院大学宁波华美医院收治2472例肺癌根治术后并发38例乳糜胸,其中肺段切除和肺叶切除各1236例,左侧胸腔镜肺癌根治手术952例,右侧胸腔镜肺癌根治手术1520例,肺段切除+系统性淋巴结根治并发16例乳糜胸,肺叶切除+系统性淋巴结根治并发22例乳糜胸,左侧胸腔镜肺癌手术后并发8例乳糜胸,右侧胸腔镜肺癌手术后并发30例乳糜胸的临床资料。结果胸腔镜肺癌术后乳糜胸的总发生率为1.54%,肺段组术后乳糜胸的发生率为1.29%,肺叶组为1.78%,两者无显著差异（P=0.32）。左侧胸腔镜肺癌术后乳糜胸的发生率为0.63%,右侧胸腔镜肺癌术后乳糜胸的发生率为2.11%,两者有显著差异（P<0.001）;所有病例均行保守治疗成功,无死亡病例。结论肺癌术后乳糜胸的发生和肺癌手术部位明显相关,与手术方式无明显相关;肺癌术后乳糜胸的营养支持治疗使保守治疗的有效率不断提高。

关键词: 肺癌, 乳糜胸, 胸腔镜

CLC Number:

R734.2
R655

HAN Le-yang, ZENG Chao, ZHAO Long. Analysis of the effects of different sites and surgical approaches on thoracoscopic radical lung cancer surgery complicated by celiac disease[J]. Lingnan Modern Clinics In Surgery, 2023, 23(01): 26-30.

韩乐洋, 曾超, 赵龙. 不同部位及手术方式对胸腔镜肺癌根治术并发乳糜胸的影响分析[J]. 岭南现代临床外科, 2023, 23(01): 26-30.

References

[1] Bade BC, Dela Cruz CS.Lung Cancer 2020: Epidemiology, Etiology, and Prevention[J]. Clin Chest Med, 2020, 41(1):1-24.
[2] Zeng W, Zhang W, Zhang J, et al.Systematic review and meta-analysis of video-assisted thoracoscopic surgery segmentectomy versus lobectomy for stage I non-small cell lung cancer[J]. World J Surg Oncol, 2020, 18(1):44.
[3] Abbas AE.Surgical Management of Lung Cancer: History, Evolution, and Modern Advances[J]. Curr Oncol Rep, 2018, 20(12): 98.
[4] Manerikar A, Querrey M, Cerier E, et al.Comparative Effectiveness of Surgical Approaches for Lung Cancer[J]. J Surg Res, 2021, 263:274-284.
[5] Sarkaria IS, Finley DJ, Bains MS, et al.Chylothorax and recurrent laryngeal nerve injury associated with robotic video-assisted mediastinal lymph node dissection[J]. Innovations (Phila), 2015,10(3): 170-173.
[6] Ferguson MK,Little AG,Skinner DB.Current concepts in the management of postoperative chylothorax[J].Ann Thorac Surg, 1985,40(6):542 545.
[7] 吴卓鹏,杨劼.胸外科手术后继发乳糜胸的防治[J]. 岭南现代临床外科, 2021,21(6): 688-693.
[8] Wemyss-Holden SA, Launois B, Maddern GJ.Management of thoracic duct injuries after oesophagectomy[J]. Br J Surg, 2001,88(11): 1442-1448.
[9] Chen C, Wang Z, Hao J, et al.Chylothorax after Lung Cancer Surgery: A Key Factor Influencing Prognosis and Quality of Life[J]. Ann Thorac Cardiovasc Surg, 2020, 26(6): 303-310.
[10] Cho HJ, Kim DK, Lee GD, et al.Chylothorax complicating pulmonary resection for lung cancer: effective management and pleurodesis[J]. Ann Thorac Surg, 2014, 97(2): 408-413.
[11] Bryant AS, Minnich DJ, Wei B, et al.The incidence and management of postoperative chylothorax after pulmonary resection and thoracic mediastinal lymph node dissection[J]. Ann Thorac Surg, 2014, 98(1): 232-235.
[12] 张旭刚,李维青,李宝重,等. 肺癌根治术后乳糜胸发生的相关因素分析[J]. 临床肺科杂志,2021,26(05):752-756.
[13] 赵峻,张德超,汪良骏,张汝刚. 肺癌与食管癌术后乳糜胸的比较[J]. 中华外科杂志,2003,41(01):50-52.
[14] Kutlu CA, Sayar A, Olgac G, et al.Chylothorax: A complication following lung resection in patients with NSCLC-chylothorax following lung resection[J]. Thorac Cardiovasc Surg, 2003, 51(6): 342-345.
[15] Akin H, Olcmen A, Isgorucu O, et al.Approach to patients with chylothorax complicating pulmonary resection[J]. Thorac Cardiovasc Surg, 2012, 60(2): 135-139.
[16] Liu ZX,Dum J,Liang YC et al. Prophylactic ligation of the thoracic duct branch prevents chylothorax after pulmonary resection for right lung cancer[J]. Surg Today, 2020, 50(8):881-888.
[17] 徐晓迁,姜哲. 肺癌根治术后并发乳糜胸的治疗[J]. 滨州医学院学报,2013,36(03):216.
[18] Shimizu K, Yoshida J, Nishimura M,et al.Treatment strategyfor chylothorax after pulmonary resection and lymph node dissection for lung cancer[J]. J Thorac Cardiovasc Surg, 2002, 124(3): 499-502.
[19] Zabeck H, Muley T, Dienemann H, Hoffmann H.Management of chylothorax in adults: when is surgery indicated?[J]. Thorac Cardiovac Surg, 2011,59(4):243-246.